The video that Trump released on Wednesday, in which he described Regeneron’s antibody treatment as a “miracle”, further fuelled a rally in the company’s shares, which have jumped 60 per cent since January, in large part on hopes for its COVID-19 drug.
Schleifer, who trained as a neurosurgeon, founded Regeneron in 1988, setting up its headquarters not in New York City where he was born, but instead in Tarrytown, farther north on the banks of the Hudson River. Regeneron has already delivered two blockbuster drugs: Eylea, to treat macular degeneration, and Dupixent, an injection to treat eczema and asthma. Last year, the company sold US$4.6 billion worth of Eylea and US$2.3 billion worth of Dupixent.
Early trials showed that the drug could cut recovery time from 13 days to six, but only for patients whose systems had not mounted their own antibody response. For anyone whose system was already fighting the virus, Regeneron’s therapy appeared to achieve little, which is one of the reasons scientists are loath to call it a cure.
Regeneron’s rival Eli Lilly is producing a similar treatment, which it is able to manufacture more quickly since it derived its antibodies from a single source. The Indiana-based drugmaker says it expects to make 100,000 doses this month.
Regeneron discovered a way to inject human DNA into mice so their immune systems would spit out human antibodies when injected with a virus. Allowed the company to move quickly when COVID-19 came:it injected mice with the virus, and out came antibodies it could test in humans!!!
It didn’t only cure it. It knocked the virus out.
Cured? Did you heard him hacking up a lung on Hannity? Or say there's 'lingering'? No one knows what drug helped Trump. Studies are needed.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CTVNews - 🏆 1. / 99 Read more »